For the Inventor, By the Inventor

Enter assignee name

Constance, Germany

Altana Pharma Ag

USPTO Granted Patents = 84

CIPO Patents = 4

Trademarks = 4

Forward Citations = 425

Loading Chart...

Loading Chart...

65 inventors (with patents filed for the assignee):

Wilm Buhr (12 out of 23 patents)

Jörg Senn-Bilfinger (12 out of 26 patents)

Geert Jan Sterk (9 out of 28 patents)

4. Beate Schmidt (7 out of 29 patents)

5. Thomas Martin (7 out of 12 patents)

6. Rango Dietrich (6 out of 30 patents)

7. Gerhard Grundler (6 out of 20 patents)

8. Peter Jan Zimmermann (6 out of 6 patents)

9. Beate Gutterer (6 out of 13 patents)

10. Rudolf Linder (5 out of 19 patents)

11. Thomas Fuchss (5 out of 6 patents)

12. Wolf-Rüdiger Ulrich (5 out of 6 patents)

13. Jörg Senn-Bilfinger (5 out of 9 patents)

14. Dietrich Häfner (4 out of 5 patents)

15. Ulrich Kilian (4 out of 5 patents)

Core Competencies:

Benzothienopyridines

Imidazopyridine-Derivatives

Nitrate Esters

Cyclic Benzimidazoles

Pyrrolidinedione

Tryptase Inhibitors

Pulmonary Surfactant

Phthalazinone-Piperidino-Derivatives

Tricyclic Compounds

Gastrointestinal Disorders

Inducible NO-Synthase Inhibitors

PDE4 Inhibitors

84 patents: Sort by Forward Citations

1. 8044065 - Benzothienopyridines for use as inhibitors of Eg5 kinesin (2011-10-25),

2. 7781453 - Aminopyridine-derivatives (2010-08-24),

3. 7709488 - Imidazopyridine-derivatives as inducible no-synthase inhibitors (2010-05-04),

4. 7524973 - Nitrate esters of phenylaminothiophenacetic acid derivatives (2009-04-28),

5. 7468377 - Imidazopyridine-derivatives as inductible no-synthase inhibitors (2008-12-23),

6. 7393860 - Tetrahydropyridoethers (2008-07-01),

7. 7390819 - Imidazo[4,5-b]quinoline-derivatives and their use as no-synthase inhibitors (2008-06-24),

8. 7329677 - Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors (2008-02-12),

9. 7326784 - Intermediates for the preparation of tricyclic dihydropyrano-imidazo-pyridines derivatives (2008-02-05),

10. 7326718 - 8-Substituted imidazopyridines (2008-02-05),

11. 7317021 - Aminopyridine-derivatives as inductible no-synthase inhibitors (2008-01-08),

12. 7314935 - Tricyclic n-acyl compounds (2008-01-01),

13. 7307084 - Cyclic benzimidazoles (2007-12-11),

14. 7256293 - Imidazopyridine intermediates (2007-08-14),

15. 7247317 - Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS) (2007-07-24),

Altana Pharma AG is a pharmaceutical company based in Germany. They specialize in the research, development, and production of innovative drugs and medical solutions. With a focus on respiratory and dermatological conditions, Altana Pharma AG aims to improve the quality of life for patients worldwide. For more information about their products and services, please visit their official website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

84 Patents

#2 in Constance

#720 in Germany

#8,812 in the World

Constance, Germany

Altana Pharma Ag

Forward Citations = 425

65 inventors:

Wilm Buhr (12 out of 23 patents)

Jörg Senn-Bilfinger (12 out of 26 patents)

Geert Jan Sterk (9 out of 28 patents)

4. Beate Schmidt (7 out of 29 patents)

5. Thomas Martin (7 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…